Organisation paid for research Program year 2024 Source: CMS Open Payments

Arthritis Foundation Rocky Mountain Chapter

Neither a doctor nor a teaching hospital

Research payments

$209,821

62 payments

Through program year 2024, Arthritis Foundation Rocky Mountain Chapter is reported as receiving $209,821 in research payments, across 62 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2024	Research	$20,112	5
2021	Research	$9,334	5
2020	Research	$26,152	18
2019	Research	$154,223	34

Breakdown

Who paid Research payments · program years 2019–2024

AbbVie, Inc. $209,821 62 payments

Studies the money was for Research payments · program years 2019–2024

M16-766 $84,952 14 payments
M16-045 $74,593 24 payments
M16-047 $20,400 13 payments
Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema) $13,280 2 payments
A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis $6,831 3 payments
A Phase 3 Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Upadacitinib in Adolescent and Adult Subjects with Moderate to Severe Atopic Dermatitis $5,013 2 payments
A Phase 3 Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Upadacitinib in Combination with Topical Corticosteroids in Adolescent and Adult Subjects with Moderate to Severe Atopic Dermatitis $4,322 3 payments
P10-023 $430 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.